Literature DB >> 24011629

A newly emerged cutaneous leishmaniasis focus in central Iran.

Mahmoud Nateghi Rostami1, Abedin Saghafipour, Ehsan Vesali.   

Abstract

OBJECTIVES: This study was performed to evaluate the epidemiological status of cutaneous leishmaniasis (CL) in the most important endemic foci of Qom Province, central Iran. The city of Qom is the largest center for Shi'a scholarship in the world and is a significant pilgrimage destination.
METHODS: During 2006-2011, all suspected CL patients with skin lesion(s) referred to regional health centers of Ghomrood and Ghanavat regions, and all actively detected cases, were examined clinically and parasitologically for CL. Patient information was recorded and patients were categorized based on the number and size of the lesions. Odds ratios (OR) of different risk factors were calculated.
RESULTS: A total of 849 (59.2% male, 40.8% female) confirmed cases of CL were enrolled; the average incidence rate of the disease was 14.9 per 100000 people. During the study period 2006-2011, the trend in CL incidence showed no sudden variations in the areas studied, except for an outbreak of CL in 2009. Leishmania major was identified as the causative agent based on internal transcribed spacer 1 (ITS1) ribosomal DNA PCR analysis. During the study period, the age distribution of CL cases was relatively stable, with the majority (50%) of patients aged 1-25 years. Most cases (n=468; 55.1%) had a single lesion and 82 (9.6%) patients had four or more lesions (range 1-29). The risk of developing multiple lesions was significantly increased in patients with seasonal jobs (summer workers) (p=0.023; OR 1.516) and significantly decreased in patients who were affected in winter (p=0.010; OR 0.398). The risk of developing large-sized lesions (>1cm) was significantly increased in patients in the age groups>25 years (p=0.001-0.015; OR 2.5-3.5) and decreased in patients with seasonal jobs (summer workers) (p=0.005; OR 0.570).
CONCLUSIONS: The present data show the importance of CL as a health problem in suburban areas of Qom Province. In order to identify other epidemiological aspects of leishmaniasis in this area, studies on vectors and reservoirs are recommended. Since leishmaniasis caused by L. major is typically zoonotic, control measures should focus on rodents as the main reservoirs and Phlebotomus papatasi as the main vector. Awareness should be raised in the high-risk populations comprising people with diabetes, young adults (<25 years old), and those who work outdoors during the summer.
Copyright © 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cutaneous leishmaniasis; Epidemiology; Iran; Qom

Mesh:

Year:  2013        PMID: 24011629     DOI: 10.1016/j.ijid.2013.07.003

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  17 in total

1.  Cutaneous leishmaniasis: an epidemiological study in southwest of Iran.

Authors:  Shahrzad Soltani; Masoud Foroutan; Maryam Hezarian; Hamed Afshari; Mehdi Sagha Kahvaz
Journal:  J Parasit Dis       Date:  2019-01-02

2.  Epidemiologic profile of oriental sore caused by Leishmania parasites in a new endemic focus of cutaneous leishmaniasis, southern Iran.

Authors:  Moosa Khosravani; Mohammad Djaefar Moemenbellah-Fard; Mehdi Sharafi; Azam Rafat-Panah
Journal:  J Parasit Dis       Date:  2014-12-24

3.  Geographical distribution and molecular characterization for cutaneous leishmaniasis species by sequencing and phylogenetic analyses of kDNA and ITS1 loci markers in south-eastern Iran.

Authors:  Maryam Ramezany; Iraj Sharifi; Zahra Babaei; Pooya Ghasemi Nejad Almani; Amireh Heshmatkhah; Alireza Keyhani; Mohammad Reza Aflatoonian; Mohammad Ali Mohammadi; Fatemeh Sharifi; Mehdi Bamorovat
Journal:  Pathog Glob Health       Date:  2018-03-14       Impact factor: 2.894

4.  Geographic and ecological features of phlebotomine sand flies (Diptera: Psychodidae) as leishmaniasis in Central Iran.

Authors:  Hassan Vatandoost; Jalil Nejati; Abedin Saghafipour; Alireza Zahraei-Ramazani
Journal:  J Parasit Dis       Date:  2017-10-26

5.  Epidemiological features of cutaneous leishmaniasis in diagnosed patients from an endemic area (central Morocco).

Authors:  Omar Amahmid; Youssef El Guamri; Khalid Zenjari; Souad Bouhout; Mohamed Ait Moh; Fatima Boraam; Abdelaziz Ait Melloul; Hilal Benfaida; Khadija Bouhoum; Driss Belghyti
Journal:  J Parasit Dis       Date:  2021-02-13

6.  Molecular identification of Leishmania spp. isolates causes cutaneous leishmaniasis (CL) in Sanliurfa Province, Turkey, where CL is highly endemic.

Authors:  Gulcan Gurses; Mehmet Ozaslan; Fadile Yıldız Zeyrek; Ibrahim H Kılıç; Nebiye Yentür Doni; I Didem Karagöz; Nermin Uluca
Journal:  Folia Microbiol (Praha)       Date:  2017-12-07       Impact factor: 2.099

7.  Incidence and Disability-Adjusted Life Years (Dalys) Attributable to Leishmaniasis In Iran, 2013.

Authors:  Fatemeh Heydarpour; Ali Akbari Sari; Mehdi Mohebali; Mohammadreza Shirzadi; Saied Bokaie
Journal:  Ethiop J Health Sci       Date:  2016-07

Review 8.  Leishmaniasis revisited: Current aspects on epidemiology, diagnosis and treatment.

Authors:  Sarah P Georgiadou; Konstantinos P Makaritsis; George N Dalekos
Journal:  J Transl Int Med       Date:  2015-06-30

9.  Epidemiological Study on Cutaneous Leishmaniasis in an Endemic Area, of Qom Province, Central Iran.

Authors:  Abedin Saghafipour; Hassan Vatandoost; Ali Reza Zahraei-Ramazani; Mohammad Reza Yaghoobi-Ershadi; Moharram Karami Jooshin; Yavar Rassi; Mohammad Reza Shirzadi; Amir Ahmad Akhavan; Ahmad Ali Hanafi-Bojd
Journal:  J Arthropod Borne Dis       Date:  2017-09-08       Impact factor: 1.198

10.  Molecular Identification of Leishmania Species in a Re-Emerged Focus of Cutaneous Leishmaniasis in Varamin District, Iran.

Authors:  Mahmoodreza Behravan; Vahideh Moin-Vaziri; Ali Haghighi; Nourina Rahbarian; Niloofar Taghipour; Alireza Abadi; Homa Hajjaran
Journal:  J Arthropod Borne Dis       Date:  2017-03-14       Impact factor: 1.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.